Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04092673
Title Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies (Zotatifin)
Acronym Zotatifin
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Effector Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California RECRUITING Los Angeles California 90033 United States Details
Valkyrie Clinical Trials RECRUITING Los Angeles California 90067 United States Details
Hoag Memorial Hospital Presbyterian COMPLETED Newport Beach California 92663 United States Details
Stanford University RECRUITING Palo Alto California 94304 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Comprehensive Cancer Centers of Nevada COMPLETED Las Vegas Nevada 89169 United States Details
Memorial Sloan Kettering Cancer Center- Monmouth RECRUITING Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Cancer Center- Commack RECRUITING Commack New York 11725 United States Details
Memorial Sloan Kettering Cancer Center- Westchester RECRUITING Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center- David H. Koch Center for Cancer Care RECRUITING New York New York 11101 United States Details
University of Toledo Medical Center COMPLETED Toledo Ohio 43614 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
New Experimental Therapeutics of San Antonio - NEXT Oncology COMPLETED San Antonio Texas 78229 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field